Z. Younossi, Q. M. Anstee, M. Marietti, T. Hardy, L. Henry et al., Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, vol.15, pp.11-20, 2018.

Z. M. Younossi, A. B. Koenig, D. Abdelatif, Y. Fazel, L. Henry et al., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, vol.64, pp.73-84, 2016.

S. L. Friedman, B. A. Neuschwander-tetri, M. Rinella, and A. J. Sanyal, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, vol.24, pp.908-922, 2018.

C. K. Argo, P. G. Northup, A. M. Al-osaimi, and S. H. Caldwell, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, J Hepatol, vol.51, pp.371-379, 2009.

S. Singh, A. M. Allen, Z. Wang, L. J. Prokop, M. H. Murad et al., Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies, Clin Gastroenterol Hepatol, vol.13, pp.643-654, 2015.

D. E. Kleiner, E. M. Brunt, L. A. Wilson, C. Behling, C. Guy et al.,

, Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

, JAMA Netw Open, vol.2, p.1912565, 2019.

P. Angulo, D. E. Kleiner, S. Dam-larsen, L. A. Adams, and E. S. Bjornsson,

P. Mills and P. R. , Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.149, pp.389-397, 2015.

P. S. Dulai, S. Singh, J. Patel, M. Soni, L. J. Prokop et al., Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and metaanalysis, Hepatology, vol.65, pp.1557-1565, 2017.

D. Schuppan, R. Surabattula, and X. Y. Wang, Determinants of fibrosis progression and regression in NASH, J Hepatol, vol.68, pp.238-250, 2018.

C. A. Moylan, H. Pang, A. Dellinger, A. Suzuki, M. E. Garrett et al.,

, Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease, Hepatology, vol.59, pp.471-482, 2014.

M. Ahrens, O. Ammerpohl, V. Schonfels, W. Kolarova, J. Bens et al.,

, DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery, Cell Metab, vol.18, pp.296-302, 2013.

P. Lefebvre, F. Lalloyer, E. Bauge, M. Pawlak, C. Gheeraert et al.,

, Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of Accepted Article This article is protected by copyright. All rights reserved PPARalpha-regulated dermatopontin, JCI Insight, vol.2, p.92264, 2017.

A. Teufel, T. Itzel, W. Erhart, M. Brosch, X. Y. Wang et al.,

, Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients, Gastroenterology, vol.151, pp.513-525, 2016.

T. Hyotylainen, L. Jerby, E. M. Petaja, I. Mattila, S. Jantti et al.,

, Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease, Nat Commun, vol.7, p.8994, 2016.

M. P. Suppli, K. Rigbolt, S. S. Veidal, S. Heeboll, P. L. Eriksen et al.,

, Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals, Am J Physiol Gastrointest Liver Physiol, vol.316, pp.462-472, 2019.

J. T. Haas, L. Vonghia, D. A. Mogilenko, A. Verrijken, O. Molendi-coste et al.,

A. , Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution, Nature Metabolism, vol.1, pp.604-614, 2019.

M. Ryaboshapkina and M. Hammar, Human hepatic gene expression signature of nonalcoholic fatty liver disease progression, a meta-analysis, Sci Rep, vol.7, p.12361, 2017.

M. Subichin, J. Clanton, M. Makuszewski, A. Bohon, J. G. Zografakis et al., Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery, Surg Obes Relat Dis, vol.11, pp.137-141, 2015.

K. P. Souto, N. G. Meinhardt, M. J. Ramos, J. M. Ulbrich-kulkzynski, A. T. Stein et al.,

, Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review, Surg Obes Relat Dis, vol.14, pp.66-73, 2018.

M. Gershoni and S. Pietrokovski, The landscape of sex-differential transcriptome and its consequent selection in human adults, BMC Biol, vol.15, p.7, 2017.

B. Labonte, O. Engmann, I. Purushothaman, C. Menard, J. Wang et al.,

, Sex-specific transcriptional signatures in human depression, Nat Med, 2017.

A. Lonardo, F. Nascimbeni, S. Ballestri, D. Fairweather, S. Win et al., Sex Differences in NAFLD: State of the Art and Identification of Research Gaps, Hepatology, 2019.

B. Tramunt, S. Smati, N. Grandgeorge, F. Lenfant, J. F. Arnal et al., Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer, Proc Natl Acad Sci, vol.63, pp.5923-5928, 2006.

S. Michiels, S. Koscielny, and C. Hill, Prediction of cancer outcome with microarrays: a multiple random validation strategy, Lancet, vol.365, pp.488-492, 2005.

J. G. Liao and K. V. Chin, Logistic regression for disease classification using microarray data: model selection in a large p and small n case, Bioinformatics, vol.23, pp.1945-1951, 2007.

J. P. Higgins, Nonlinear systems in medicine, Yale J Biol Med, vol.75, pp.247-260, 2002.

R. Diaz-uriarte, A. De-andres, and S. , Gene selection and classification of microarray data using random forest, BMC Bioinformatics, vol.7, p.3, 2006.

A. Boulesteix, S. Janitza, J. Kruppa, and I. R. König, Overview of random forest methodology and practical guidance with emphasis on computational biology and bioinformatics, Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery, vol.2, pp.493-507, 2012.

I. Guyon, J. Weston, S. Barnhill, and V. Vapnik, Gene Selection for Cancer Classification using Support Vector Machines, Machine Learning, vol.46, pp.389-422, 2002.

D. Margerie, P. Lefebvre, V. Raverdy, U. Schwahn, H. Ruetten et al.,

, Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients, BMC Medical Genomics, vol.12, 2019.

A. Verrijken, S. Francque, I. Mertens, J. Prawitt, S. Caron et al.,

, Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Hepatology, vol.59, pp.121-129, 2014.

D. E. Kleiner, E. M. Brunt, M. Van-natta, C. Behling, M. J. Contos et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.41, pp.1313-1321, 2005.

T. M. Wallace, J. C. Levy, and D. R. Matthews, Use and abuse of HOMA modeling, Diabetes Care, vol.27, pp.1487-1495, 2004.

Q. Tang, X. Li, P. Song, and L. Xu, Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future, Drug Discov Ther, vol.9, pp.380-385, 2015.

A. M. Diehl and C. Day, Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

, Engl J Med, vol.377, pp.2063-2072, 2017.

E. Morselli, A. P. Frank, R. S. Santos, L. A. Fatima, B. F. Palmer et al., Sex and Gender: Critical Variables in Pre-Clinical and Clinical Medical Research, Cell Metab, vol.24, pp.203-209, 2016.

F. Mauvais-jarvis, Sex differences in metabolic homeostasis, diabetes, and obesity, Biol Sex Differ, vol.6, p.14, 2015.

A. M. Lichanska and M. J. Waters, How growth hormone controls growth, obesity and sexual dimorphism, Trends Genet, vol.24, pp.41-47, 2008.

E. Hashimoto and K. Tokushige, Prevalence, gender, ethnic variations, and prognosis of NASH, J Gastroenterol, vol.46, issue.1, pp.63-69, 2011.

S. Ballestri, F. Nascimbeni, E. Baldelli, A. Marrazzo, D. Romagnoli et al.,

, Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk, Adv Ther, vol.34, pp.1291-1326, 2017.

F. Chen, R. J. Jimenez, K. Sharma, H. Y. Luu, B. Y. Hsu et al.,

, Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration, Cell Stem Cell, 2019.

R. Mayo, J. Crespo, I. Martínez-arranz, and J. M. Banales,

R. , Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts, Hepatology Communications, 2018.

J. Barr, J. Caballeria, I. Martinez-arranz, A. Dominguez-diez, C. Alonso et al.,

M. Cormenzana, Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression, J Proteome Res, vol.11, pp.2521-2532, 2012.

G. C. Wood, X. Chu, G. Argyropoulos, P. Benotti, D. Rolston et al., A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains, Scientific Reports, vol.7, 2017.

S. Jacobs, E. Gart, D. Vreeken, B. Franx, L. Wekking et al.,

, Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice, Nutrients, p.11, 2019.

S. R. Ande, K. H. Nguyen, G. Nyomba, B. L. Mishra, and S. , Prohibitin-induced, obesityassociated insulin resistance and accompanying low-grade inflammation causes NASH and HCC, Sci Rep, vol.6, p.23608, 2016.

Z. Kurt, R. Barrere-cain, J. Laguardia, M. Mehrabian, C. Pan et al.,

, Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease, Biol Sex Differ, vol.9, p.46, 2018.

S. L. Friedman, V. Ratziu, S. A. Harrison, M. F. Abdelmalek, G. P. Aithal et al.,

S. , A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis, Hepatology, vol.67, pp.1754-1767, 2018.

, Author names in bold indicate shared co-first authorship